A View LCS vs FibriCheck
AI Verdict
Choose AVIEW LCS if…
Choose AVIEW LCS if your clinical practice requires a comprehensive, AI-powered solution for analyzing thoracic CT scans. This tool is best suited for radiologists and pulmonologists needing automated detection, quantification, and reporting for lung nodules, emphysema, and coronary artery calcification from a single low-dose CT. It streamlines the diagnostic workflow for multiple thoracic diseases.
View AVIEW LCS →Choose FibriCheck if…
Choose FibriCheck if you need a convenient and accessible solution for remote patient monitoring of heart rhythms using a smartphone. This tool is ideal for healthcare providers looking to empower patients to regularly check for arrhythmias like AFib, providing immediate results and a professional portal for oversight. It facilitates ongoing cardiac care and early detection of irregularities outside of the clinic.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | FibriCheck |
|---|---|---|
| Pricing | Subscription or one-off payment | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Cloud-based (private cloud). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FibriCheckFibriCheck is a patient-facing mobile application designed for ease of use on a smartphone, making it highly accessible for a broad user base to monitor heart rhythm. A View LCS is a sophisticated medical imaging platform for professionals, requiring integration into existing clinical workflows and likely specialized training for optimal use.
Clinical Value
AVIEW LCSA View LCS offers comprehensive diagnostic insights from a single low-dose CT scan, covering multiple critical conditions like lung cancer, emphysema, and coronary artery calcification with detailed quantification and reporting. While FibriCheck provides valuable remote monitoring for arrhythmias, A View LCS delivers a broader and deeper diagnostic impact within a clinical setting.
Pricing & Value
FibriCheckFibriCheck provides transparent and detailed pricing information for both end-users and healthcare providers, including various subscription models and short-term options. In contrast, A View LCS requires contacting the vendor for a quote, which makes it challenging for potential users to readily assess its cost-effectiveness without direct engagement.
Enterprise Readiness
AVIEW LCSA View LCS offers a wide array of deployment options, including cloud, hybrid, dedicated hardware, and virtualized solutions, providing flexibility for diverse enterprise IT infrastructures. It also explicitly states HIPAA compliance and a Business Associate Agreement (BAA). FibriCheck is primarily a cloud-based application with an implied BAA, offering less deployment versatility for complex enterprise environments.
Innovation
AVIEW LCSA View LCS demonstrates significant innovation by integrating comprehensive AI-powered analysis for multiple thoracic diseases (lung cancer, emphysema, coronary artery calcification) from a single low-dose CT scan, including advanced features like CT kernel conversion AI technology. FibriCheck's innovation lies in democratizing heart rhythm monitoring via smartphone cameras, but A View LCS pushes the boundaries of multi-modal diagnostic imaging AI further.
Support & Docs
FibriCheckFibriCheck offers publicly accessible support resources, including a comprehensive help center with FAQs, user manuals, and contact options for both individuals and healthcare providers. For A View LCS, while technical documentation and catalogs are available, explicit details on public support channels, SLAs, or readily accessible user documentation were not as transparently available through general web searches, which is typical for enterprise-level medical software.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | FibriCheck |
|---|---|---|
| Name | A View LCS | FibriCheck |
| Company | Coreline Soft Co. | Qompium nv |
| Description | AVIEW LCS by Coreline Soft is an FDA-cleared AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. | FibriCheck is a medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone. |
| Primary Categories | Cardiology AI, Oncology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Key Features (Cardiology) | Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass), Segmentation of major coronary arteries | Smartphone camera-based PPG technology for heart rhythm measurement, AI-powered algorithm for arrhythmia detection and analysis, Detection of Atrial Fibrillation (AFib) and other arrhythmias |
| Key Features (Other) | Automated lung nodule detection and classification, Nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting, Emphysema analysis and quantification (LAA), Automated comprehensive report generation (PDF, DICOM PDF, SR), CT kernel conversion AI technology | Healthcare professional portal/dashboard for patient monitoring, Patient-facing mobile application, Immediate and actionable results, Ability to log blood pressure and weight, Customizable monitoring rules for healthcare providers |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and FibriCheck.